EP 1229915 A4 20030514 - PROTEASE INHIBITORS
Title (en)
PROTEASE INHIBITORS
Title (de)
PROTEASEHEMMER
Title (fr)
INHIBITEURS DE PROTEASE
Publication
Application
Priority
- US 0030758 W 20001108
- US 16456299 P 19991110
Abstract (en)
[origin: WO0134160A1] This invention relates to the compound of Formula (I) or a pharmaceutical acceptable salt, hydrate or solvate thereof, which is an inhibitor of cystein proteases, particularly cathepsin K, and is useful in the treatment of diseases in which inhibition of bone loss or of cartilage degradation is a factor.
IPC 1-7
IPC 8 full level
A61K 31/55 (2006.01); A61P 1/02 (2006.01); A61P 19/02 (2006.01); A61P 19/08 (2006.01); A61P 19/10 (2006.01); A61P 29/00 (2006.01); A61P 43/00 (2006.01); B01D 15/08 (2006.01); C07B 57/00 (2006.01); C07D 401/14 (2006.01)
CPC (source: EP)
A61K 31/55 (2013.01); A61P 1/02 (2017.12); A61P 19/02 (2017.12); A61P 19/08 (2017.12); A61P 19/10 (2017.12); A61P 29/00 (2017.12); A61P 43/00 (2017.12); C07D 401/14 (2013.01); Y02A 50/30 (2017.12)
Citation (search report)
- [X] WO 9805336 A1 19980212 - SMITHKLINE BEECHAM CORP [US], et al
- See references of WO 0134160A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0134160 A1 20010517; EP 1229915 A1 20020814; EP 1229915 A4 20030514; JP 2003513928 A 20030415
DOCDB simple family (application)
US 0030758 W 20001108; EP 00978442 A 20001108; JP 2001536158 A 20001108